Scientists at NYU have created a drug that targets cancer-causing HER2 mutations without harming healthy cells. This new ...

Rachel Connor, Director of Research Partnerships at Breakthrough T1D, believes this pioneering study could “pave the way” for ...

Ludwig Cancer Research scientists have devised new types of chimeric antigen-receptor (CAR) T cells—a type of cancer ...

Metabolic profiling, toxicity screening, and other services are available to researchers in drug discovery, tissue banks, cultivated meats and sports science.

Immutep (ASX:IMM) has made significant progress over the past year with its lead immunotherapy candidate, eftilagimod alpha ...

Ludwig Cancer Research scientists have devised new types of chimeric antigen-receptor (CAR) T cells-;a type of cancer immunotherapy-;that can be switched on to varying degrees of intensity and then ...

Researchers from Osaka University discover that the GPR31 path in 'gut surveillance' cells detects bacterial metabolites and ...

Aura Biosciences has been able to advance its pipeline with great clinical success recently. Click here to read an analysis ...

A team at Texas A&M University is using pig skin cells to explore the use of photodynamic therapy to treat melanoma in humans ...

A combination of two drugs that can block the growth of cancer cells has shown promising results in women with a form of ...